Pelosi drug pricing plan could impact covered entities
As 340B Health reports, a new proposal unveiled September 19 by House Speaker Nancy Pelosi, the “Lower Drugs Costs Now Act” (H.R.3), aims to bring down drug prices by allowing Medicare to negotiate prices on certain high-cost drugs and capping…
Sentry celebrates as a proud partner in National Health IT Week
This September 23-27, Sentry is once again a proud partner of U.S. National Health IT Week (NHIT). The theme this year is Supporting Healthy Communities and driving transformation of our health and wellness ecosystem to promote better health…
Sentry Data Systems reaches settlement agreement with CVS and Wellpartner
Sentry Data Systems, Inc. has reached a settlement agreement to resolve its litigation with CVS Pharmacy, Inc. and Wellpartner, LLC. The parties are in the process of memorializing the terms of the agreement and expect to be in a position…
Sentry’s Head of Industry Relations delivers expert 340B insights to healthcare executives
Lisa Scholz, Head of Industry Relations at Sentry Data Systems, recently participated in an online webinar series for the Texas Healthcare Trustees. The presentations, “340B – Understanding the Basics” and “Strategic 340B Insights…
RXinsider video series highlights leading 340B experts
In a new video series from RXinsider, leading healthcare experts discuss the key factors in selecting a 340B administrator, how to stay ahead of the ever-changing 340B regulatory environment, how the right compliance technology can help hospitals…
Expect more with Sentry — your partner for 340B transparency!
When it comes to 340B, transparency simply means sharing your story — the whole story, with the benefits AND costs that come with running your 340B program.
Sentry’s Chief Medical Officer published in Pharmaceutical Executive
William Kirsh, DO, MPH, Chief Medical Officer of Sentry Data Systems, has published an article in Pharmaceutical Executive magazine. The article, “A Broken System – Making Drug Decisions without Real-World Data,” discusses how using real-world data and real-world evidence to make formulary drug decisions can benefit both patients and health systems.
Sentry's Vice President of Human Resources recognized by South Florida Business & Wealth
Sally Cornet, MBA, SPHR, GPHR and Vice President of Human Resources at Sentry Data Systems, was recently recognized as an outstanding HR professional by South Florida Business & Wealth.
Sentry Data Systems ignites innovation engine: Announces groundbreaking patent for care improvement and cost reduction technology
Sentry recently announced the award of a patent related to its Care Improvement and Cost Reduction Analytics Methodology. The patented technology promises to radically change the trajectory of healthcare.
Judge rules Sentry can continue CVS lawsuit
Sentry cleared an important hurdle in its litigation against CVS Pharmacy Inc. (“CVS”) on Wednesday when a federal court denied in its entirety CVS’s motion to dismiss Sentry’s lawsuit against CVS.
